cisplatin chemotherapy

DRUG4 trials

Sponsors

Swedish Orphan Biovitrum, GlaxoSmithKline, European Organisation for Research and Treatment of Cancer - EORTC, Cedars-Sinai Medical Center

Conditions

HPV Positive Oropharyngeal Squamous Cell CarcinomaHead and Neck CancerMucositisNeoplasms, Head and NeckSolid TumorsSquamous Cell CarcinomaStomatitisUterine Cervical Neoplasms

Phase 2

Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer

CompletedNCT00387127

GlaxoSmithKlineNeoplasms, Head and Neck

Start: 2006-11-30End: 2014-01-31Updated: 2015-06-25

A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer

WithdrawnNCT02501278

European Organisation for Research and Treatment of Cancer - EORTCUterine Cervical Neoplasms

Start: 2016-05-31End: 2021-05-31Updated: 2016-05-13

Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer

Active, not recruitingNCT04502407

Cedars-Sinai Medical CenterHPV Positive Oropharyngeal Squamous Cell Carcinoma

Start: 2021-02-16End: 2029-12-15Target: 40Updated: 2026-08-05

Phase 3

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

CompletedNCT00101582

Swedish Orphan BiovitrumHead and Neck Cancer, Mucositis, Solid Tumors +2

Start: 2005-08-31End: 2016-08-31Updated: 2016-09-27

Related Papers

The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.

2014-07-2359 citations